These weight loss drugs are expensive out of pocket, though. Even with insurance, high co-pays can also limit who has access to them.

People struggling with their body weight experienced joy when new, more effective prescription drug options became the rage in 2023, but it seems many folks stopped taking them in 2024.

Initial research has focused on obesity, but Ozempic, Wegovy and Mounjaro may potentially be used for addiction, heart disease and Alzheimer’s

Prescriptions for weight-loss drugs surged in 2024 and were much more popular in some states, particularly those in the South with higher rates of obesity.

In addition, the decline in overall obesity rate reported by the CDC isn’t the first such drop. Between 1999 and 2018, the NHANES results found two instances of slight decreases in obesity rates and two dips in severe obesity rates. These falls were followed by steady increases in both categories.

Clinical trials have shown that people using weight-loss jabs, such as Wegovy and Mounjaro, lose anywhere between 16% and 21% of their body weight. But the drugs don’t work for everyone. In tho

Meds like Wegovy are all over the news. But are they right for you, especially if you’re older than the average user?

As demand for obesity drugs like Wegovy, Zepbound, Mounjaro and Ozempic, outpaces supply, online scams are rising, according to cybersecurity experts.